“…Other STAT target genes are involved in cancer signaling to regulate cell proliferation (e.g., cyclin D, HSP90), apoptosis (e.g., BCL-2, MCL-1, Bcl-xL), angiogenesis (e.g., VEGF-A, FGF), metastasis (e.g., MMP1-3, Vimentin, ICAM-1) and signaling (e.g., AKT, PI3K, TNF-R2) [113]. [18,20,41,106,108,109] while stimulating proliferation [20,41,106,108,113], migration, invasion [113][114][115][116][117][118], and resistance to chemotherapy [107]. These functions of TYK2 lead to increased tumor aggressiveness and metastasis [14,20,22,36,106], resulting in greater patient mortality.…”